NEXVAP creates “R-Evolutionary lifestyle device” for medical drugs and nicotine replacement therapies. NEXVAP needs to raise 13 to 15 million euros over a three year period to sustain its development.
• Turning smoking cessation & drug inhalation into an enjoyable and safer habit is key – E-cigarette market expected to grow to $ 50 bn in 2025 and Nicotine Replacement
Therapy market estimated to reach $ 22 bn in 2024
Developing and selling consumer-focused, life-style oriented devices
Discover more by video: httpss://youtu.be/VmOyjCXAa1